Decoding cancer heterogeneity: studying patient-specific signaling signatures towards personalized cancer therapy

The past years have witnessed a rapid increase in the amount of large-scale tumor datasets. The challenge has now become to find a way to obtain useful information from these masses of data that will allow to determine which combination of FDA-approved drugs is best suited to treat the specific tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Flashner-Abramson, Efrat, Vasudevan, Swetha, Adejumobi, Ibukun Adesoji, Sonnenblick, Amir, Kravchenko-Balasha, Nataly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691586/
https://www.ncbi.nlm.nih.gov/pubmed/31410207
http://dx.doi.org/10.7150/thno.31657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691586/
https://www.ncbi.nlm.nih.gov/pubmed/31410207
http://dx.doi.org/10.7150/thno.31657

Ejemplares similares